The risks that are documented
Conversation about peptides tends to focus on whether a compound works. The actual harm in this space comes from somewhere less glamorous: contamination, incorrect dosing arithmetic, and drug interactions nobody checked. Before any compound-specific reading, these are the things worth knowing.
Sterility is the whole ballgame
Anything injected must be sterile. A lyophilised powder from a research supplier is not a sterile pharmaceutical product — it becomes one, or does not, depending on how it is handled after you receive it.
- Bacteriostatic water contains benzyl alcohol, which inhibits bacterial growth. Plain sterile water does not. If a vial will be used across multiple punctures, that distinction matters.
- Swab every vial stopper with an alcohol wipe and let it dry before piercing it.
- Never reuse a needle or syringe. Ever.
- Store reconstituted peptide refrigerated, and follow the supplier's guidance on how long it remains usable.
An infection introduced by a contaminated vial is a medical emergency, and it is the most common serious harm associated with self-administered research peptides.
The arithmetic problem
Reconstituting a powder means calculating concentration, and then converting that concentration into a volume. Many people get this wrong at least once. The failure mode is not a mild error — it is a ten-fold overdose.
Write the arithmetic down before you touch anything:
- How many milligrams are in the vial?
- How many millilitres of diluent are you adding?
- Concentration = milligrams divided by millilitres.
- Desired dose divided by concentration = volume to draw.
Then have someone else check it, or check it again a day later. A syringe that reads in units rather than millilitres is a common source of error — confirm what one unit on your specific syringe actually represents.
Interactions are the quiet risk
Peptides are not inert because they are natural. Several act on systems where medication is already in play:
- GLP-1 and GIP agonists slow gastric emptying, which changes how oral medication is absorbed and matters enormously before surgery.
- Growth-hormone secretagogues raise IGF-1 and can worsen insulin resistance.
- Angiogenesis-promoting compounds are a theoretical concern alongside anticoagulants and in anyone with a cancer history.
- Immune modulators conflict directly with immunosuppressant therapy.
If you take prescription medication, the only defensible move is to tell the clinician prescribing it what you are considering.
Populations where the answer is no
There is no human safety data for most of these compounds in pregnancy or breastfeeding. None. The answer is not to start low — it is no. The same applies to anyone with active cancer, uncontrolled pituitary or adrenal disease, or a serious bleeding disorder.
Buy from someone who publishes testing
A certificate of analysis should name the compound, state purity as a percentage, identify the analytical method (HPLC and mass spectrometry are the expected pair), and be traceable to the batch you actually received. A generic PDF that could belong to any vial is worthless.
If a supplier cannot answer a direct question about their testing in writing, that is your answer.
What to do when something goes wrong
If you experience chest pain, difficulty breathing, a spreading rash, fever, or swelling at an injection site that worsens rather than settles — seek medical attention, and tell them exactly what you took and how much. Withholding that information to avoid embarrassment is how a manageable situation becomes a dangerous one. Clinicians are there to help, not to judge.